Kromek, the Country Durham-based developer and manufacturer of radiation detection equipment had a very busy September as the company exhibited its latest systems and products at three national and international
Kromek, the Country Durham-based developer and manufacturer of radiation detection equipment will exhibit its latest systems and products at the 2022 International Security Expo being held in London. Stand A58 Counter Threat
The threats the World faces from Chemical Biological Radiological and Nuclear (CBRN) substances are probably higher than they have ever been. Arguably, biological, radiological and nuclear weapons of mass destruction
Kromek Group plc designs, develops and produces x-ray and gamma-ray imaging and radiation detection products for the medical, CBRNe security, Homeland Security and civil nuclear radiation detection markets.
Kromek will be exhibiting at the The Emergency Services Show from Wednesday 21st to Thursday 22nd September 2022 at Hall 5, The National Exhibition Centre (NEC), Birmingham. We will be showcasing our world leading radiation detection solutions,
Kromek will be exhibiting at the CBRNe Protection Symposium 2022 from Tuesday 20th to Thursday 22nd September 2022 at Malmö, Sweden. We will be showcasing our world leading radiation detection solutions, including our D3S ID, a
The 6th Workshop on Medical Applications of Spectroscopic X-ray Detectors (SpecXray), hosted by CERN, is a prestigious, invite-only event in Switzerland, whereby experts across a range of medical fields get to
On 31 December 2019, the World Health Organization was made aware of a cluster of cases of an unknown respiratory disease in the lesser-known Chinese city of Wuhan. The disease
Kromek Group plc (LON:KMK), a leading developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments, has announced that it has completed a fundraising of
The chief executive of Sedgefield-based detection technology developer Kromek has said that it has “ended the year in better a position than we began it”, after reporting an increase in
© 2023 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
